Cargando…
Atrial fibrillation and ischaemic heart disease: should we use acetylsalicylic acid beside anticoagulants?
Coexistence of atrial fibrillation and ischaemic heart disease is very common and patients affected by these conditions are exposed to both a high ischaemic and haemorrhagic risk. The choice of an appropriate combination of anticoagulant therapy with single or dual antiplatelet treatment is indeed o...
Autores principales: | Volpe, Massimo, Gallo, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673601/ https://www.ncbi.nlm.nih.gov/pubmed/33239994 http://dx.doi.org/10.1093/eurheartj/suaa159 |
Ejemplares similares
-
Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021) -
The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation
por: El-Battrawy, Ibrahim, et al.
Publicado: (2023) -
Atrial fibrillation in heart failure: what should we do?
por: Kotecha, Dipak, et al.
Publicado: (2015) -
Should We Be Screening for Ischaemic Heart Disease Earlier in Childhood?
por: Bassareo, Pier Paolo, et al.
Publicado: (2022) -
Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation?
por: Induruwa, Isuru, et al.
Publicado: (2022)